Surmodics Reports Real-World Pounce Thrombectomy System Findings
Surmodics (Nasdaq:SRDX) announced results from a sex-specific analysis of real-world patients in a study of its Pounce thrombectomy system.
The analysis evaluated 160 acute, subacute and chronic thrombotic limb ischemia patients from the PROWL registry, with findings presented by Peter Monteleone at the 2025 Transcatheter Cardiovascular Therapeutics conference in San Francisco.
The PROWL registry collects real-world efficacy and safety outcomes for endovascular interventions using the fully mechanical, non-aspiration-based Pounce system, which is designed for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
- The registry includes up to 500 patients across up to 30 sites.
- The Pounce system is described as a "grab-and-go" solution, deployable and simple to use.
- Each system features a delivery catheter, a basket wire, and a funnel catheter.
Surmodics, based in Eden Prairie, Minnesota, developed the Pounce system.
No direct quote available in the text.
Author's summary: Surmodics reports real-world findings on Pounce thrombectomy system.
More News
- Plan ahead with wildfire prevention and mitigation tips - High Plains Journal
- Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
- The Tech Symphony: AI's Crescendo and the Gadget Orchestra
- Boomers, your star sign says this nostalgic TV show is basically your life - MediaFeed
- Danielle Smith: Balancing the budget gets a lot easier if you build a pipeline
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men
- CNN announces election night coverage plans, including All Access-only ‘livecast’
- Animal Crossing: New Horizons Gets a Free Update and Switch 2 Edition
- Ahsoka Season 2 Gets Exciting Update From Rosario Dawson
- Eala falls to Mboko to exit Hong Kong Open